Sacubitril/valsartan improves nocturia in hypertensive patients: a pilot study

The present study suggests that cardiovascular disease (CVD) may be an often-overlooked factor in the cause of nocturia. Therefore, a multidisciplinary approach is essential for the management of NP, and there is a need to promote collaboration between specialties with an emphasis on developing more patient-specific treatments.